Classification-based pathway analysis using GPNet with novel P-value computation.
other
Where this comes from
- Record sourced from PubMed, PMID 39879387.
- Also identified by DOI 10.1093/bib/bbaf039 and PMC identifier 11775473.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Pathway analysis plays a critical role in bioinformatics, enabling researchers to identify biological pathways associated with various conditions by analyzing gene expression data. However, the rise of large, multi-center datasets has highlighted limitations in traditional methods like Over-Representation Analysis (ORA) and Functional Class Scoring (FCS), which struggle with low signal-to-noise ratios (SNR) and large sample sizes. To tackle these challenges, we use a deep learning-based classification method, Gene PointNet, and a novel $P$-value computation approach leveraging the confusion matrix to address pathway analysis tasks. We validated our method effectiveness through a comparative study using a simulated dataset and RNA-Seq data from The Cancer Genome Atlas breast cancer dataset. Our method was benchmarked against traditional techniques (ORA, FCS), shallow machine learning models (logistic regression, support vector machine), and deep learning approaches (DeepHisCom, PASNet). The results demonstrate that GPNet outperforms these methods in low-SNR, large-sample datasets, where it remains robust and reliable, significantly reducing both Type I error and improving power. This makes our method well suited for pathway analysis in large, multi-center studies. The code can be found at https://github.com/haolu123/GPNet_pathway">https://github.com/haolu123/GPNet_pathway.
Medical subject headings
- Computational Biology
- Breast Neoplasms
- Deep Learning